NCT05190016 Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19 Status COMPLETED Phase N/A
NCT05188677 Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults Status COMPLETED Phase PHASE3
NCT05187793 Study of Efficacy of Different Treatment Regimens of Olokizumab Status UNKNOWN Phase PHASE3
NCT05185934 The Effect of Dietary Intervation on Endothelial Glycocalyx in COVID-19 Patients. Status UNKNOWN Phase NA
NCT05185804 Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 Status COMPLETED Phase PHASE3
NCT05185700 Symptoms ,Signs and Complications That Appear After Infection With Covid 19 Virus Status UNKNOWN Phase N/A
NCT05185674 Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors. Status COMPLETED Phase N/A
NCT05185284 Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19 Status COMPLETED Phase PHASE3
NCT05184218 Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19 Status TERMINATED Phase PHASE1
NCT05184192 Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction Status COMPLETED Phase PHASE2
NCT05184166 Hospital Management and 1-year Outcome of Patients Aged 70 Years and Older With Severe COVID-19 Status COMPLETED Phase N/A
NCT05184127 Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19 Status COMPLETED Phase PHASE2
NCT05184114 Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance Status COMPLETED Phase NA
NCT05184101 Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) Status WITHDRAWN Phase PHASE2/PHASE3
NCT05182567 GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19) Status UNKNOWN Phase PHASE1
NCT05182515 Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies Status UNKNOWN Phase PHASE3